High-Dose Insulin and Dextrose for Beta-Blocker and Calcium Channel Blocker Cardiac Arrest
High-dose insulin (1 unit/kg bolus followed by 1-10 units/kg/hour infusion) with concurrent dextrose supplementation is a Class 1 recommendation for both beta-blocker and calcium channel blocker-induced cardiac arrest and should be administered immediately alongside standard ACLS protocols. 1
Immediate Management Algorithm
For Active Cardiac Arrest
- Initiate standard ACLS with chest compressions and defibrillation as indicated 1
- Administer high-dose insulin immediately: 1 unit/kg IV bolus followed by continuous infusion at 1-10 units/kg/hour 1
- Give IV calcium in addition to insulin during cardiac arrest (Class 1 recommendation for CCB overdose) 1, 2
- Consider lipid emulsion therapy (20% lipid emulsion: 100 mL bolus followed by infusion) as a Class 1 recommendation for cardiac arrest scenarios 1, 2
- Prepare for VA-ECMO if available, as it shows 77% survival rates in refractory CCB overdose and should be considered early 1, 3
Insulin Dosing Specifics
Starting regimen: 1
- Bolus: 1 unit/kg IV push (range reported 0.5-10 units/kg in literature) 4, 5
- Infusion: Begin at 1 unit/kg/hour, titrate up to 10 units/kg/hour based on hemodynamic response 1, 4
- Maximum doses: Infusions as high as 22 units/kg/hour have been used successfully in severe cases 5
Use concentrated insulin preparations (20 units/mL) to minimize fluid overload risk—this can save up to 16 liters of fluid administration compared to standard 1 unit/mL concentrations 6, 7
Dextrose Management Protocol
Concurrent Dextrose Administration
- Start dextrose infusion immediately with insulin initiation to prevent hypoglycemia 1, 8
- Use concentrated dextrose (≥20% concentration) to reduce hypoglycemia risk—hypoglycemia occurs in 50% of patients with ≤10% dextrose vs. 30% with ≥20% dextrose 6, 4
- Typical dextrose rates: 0.5-1 g/kg/hour, adjusted to maintain euglycemia 8, 4
Monitoring Requirements
- Check blood glucose every 15-30 minutes initially, then hourly once stable 6, 4, 9
- Monitor serum potassium every 1-2 hours—hypokalemia occurs in 29-53% of patients due to intracellular potassium shift 6, 4, 9
- Continue glucose monitoring for 24 hours after insulin discontinuation as hypoglycemia can persist 5, 9
Critical Pitfalls to Avoid
Hypoglycemia Prevention
Hypoglycemia is the most common adverse event (occurring in 31-80% of cases depending on dextrose concentration used) 6, 4, 9. To minimize risk:
- Never use dextrose concentrations below 20% 6, 4
- Anticipate needing dextrose infusion rates up to 650 mL/hour of D10% 7
- Have D50W immediately available at bedside 4, 9
Hypokalemia Management
Hypokalemia develops in 29-53% of patients and represents intracellular potassium shift, not total body depletion 6, 4, 9. Aggressively replace potassium to maintain levels >3.0 mEq/L 9.
Fluid Overload Risk
Volume overload occurred in 50-65% of patients in observational studies 6. Using concentrated insulin (16-20 units/mL) dramatically reduces this risk 6, 7.
Vasopressor Considerations
- Vasopressors (norepinephrine/epinephrine) are Class 1 recommendations for both BB and CCB overdose 1
- Taper vasopressors as insulin takes effect—insulin improves inotropy and reduces need for vasoconstrictors, which can cause ischemic complications 1, 9
- In one case series, all 7 patients on vasopressors were successfully weaned after insulin initiation 9
Duration of Therapy
- Median insulin infusion duration: 16-24 hours 6, 9
- Continue dextrose for 24-48 hours post-insulin due to prolonged drug effects, especially with sustained-release formulations 1, 5, 9
- CCB effects are particularly prolonged with sustained-release preparations (diltiazem, verapamil, nifedipine) and long half-life agents (amlodipine) 1
Mechanism of Benefit
High-dose insulin works through three mechanisms: 5
- Increased cardiac inotropy independent of beta-receptors
- Enhanced intracellular glucose transport to fuel cardiomyocytes
- Peripheral vasodilation reducing afterload
Animal studies demonstrate insulin superiority over calcium, glucagon, epinephrine, and vasopressin for survival in BB/CCB overdose 5.